Alliances | Cadila Pharmaceuticals

Collaboration that brings change

We collaborate with reputed organisations with the vision to bring revolution in the healthcare sector. Their firm belief in Cadila’s philosophy has helped us together create a valuable impact in the society.

Apollo Hospitals

In 2006, Cadila Pharmaceuticals entered into a joint venture with Apollo Hospitals Group to manage Apollo Hospitals, Ahmedabad. Over the last decade, it has been recognized as a centre of excellence and has emerged as a trusted destination for the patients in the region.

Stemcyte

In 2008, Cadila Pharmaceuticals formed a JV with StemCyte Inc. USA, organization dedicated to the collection, processing, testing and storage of both – private and public umbilical cord blood units and its therapeutic applications.

Lipidor

Under a research collaboration agreement with Lipidor, Cadila Pharmaceuticals has initiated a phase 3 clinical trial for the development of differentiated Calcipotrial formulation ( Spray) for the treatment of Psoriasis.

Aplagon

In 2017, Cadila Pharmaceuticals entered into a collaboration with Aplagon Oy, Finland for development and commercialization of heparin proteoglycan mimetic for use in certain vascular surgeries.

EQL Pharma

In 2015, Cadila Pharmaceuticals entered into a strategic agreement with Sweden based EQL Pharma for product development, manufacturing and marketing in the Nordic region.